Rob Houghtaling is the Senior Director of Corporate Development for Gate Neurosciences. Rob brings more than 10 years of commercial and portfolio strategy, business development, and transaction experience within the early-stage biopharma industry.

Rob spent his early career as a strategy consultant at Health Advances, LLC, advising >50 life sciences companies on engagements spanning commercial assessments, portfolio planning, forecasting, diligence, and competitive and market research. He then served as a deal associate at Locust Walk Partners, LLC, advising on buy- and sell-side transactions for emerging biopharma companies, which culminated in several strategic partnerships worth nearly $2B. More recently, Rob founded Morningview Life Sciences in 2018 to provide strategy and BD consulting services to Seed/Series A-stage companies, focused primarily in neuropsychiatry. His background is in biomedicine and entrepreneurship, working with several startups in connection with bioengineering laboratories in academia.

Rob received his Master of Science from Columbia University and BS in Biomedical Engineering from the University of Virginia.